BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

832 related articles for article (PubMed ID: 33944541)

  • 1. Successful desensitization with chemotherapeutic drugs: a tertiary care center experience.
    Çakmak ME; Kaya SB; Can Bostan Ö; Öztürk Aktaş Ö; Damadoğlu E; Karakaya G; Kalyoncu AF
    Eur Ann Allergy Clin Immunol; 2022 Mar; 54(2):90-94. PubMed ID: 33944541
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypersensitivity Reaction and Rapid Drug Desensitization with Chemotherapeutics: A Tertiary Reference Center Experiences.
    Bulut İ; Yegin Katran Z
    Int Arch Allergy Immunol; 2023; 184(9):849-855. PubMed ID: 37442106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of 490 Desensitizations to Chemotherapy Drugs with a Rapid One-Solution Protocol.
    Pérez-Rodríguez E; Martínez-Tadeo JA; Pérez-Rodríguez N; Hernández-Santana G; Callero-Viera A; Rodríguez-Plata E; García-Robaina JC
    J Allergy Clin Immunol Pract; 2018; 6(5):1621-1627.e6. PubMed ID: 29361511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new non-dilution rapid desensitization protocol successfully applied to all-grade platinum hypersensitivity.
    Chung SJ; Kang SY; Kang RY; Kim YC; Lee KH; Kim TY; Han SW; Kang HR
    Cancer Chemother Pharmacol; 2018 Nov; 82(5):777-785. PubMed ID: 30105458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypersensitivity reactions to oxaliplatin: a retrospective study and the development of a desensitization protocol.
    Syrigou EI; Karapanagiotou EM; Alamara CV; Boura PG; Saif MW; Syrigos KN
    Clin Colorectal Cancer; 2009 Apr; 8(2):106-9. PubMed ID: 19739272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and management of hypersensitivity reactions caused by oxaliplatin.
    Herrero T; Tornero P; Infante S; Fuentes V; Sánchez MN; De Barrio M; Baeza ML
    J Investig Allergol Clin Immunol; 2006; 16(5):327-30. PubMed ID: 17039675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases.
    Castells MC; Tennant NM; Sloane DE; Hsu FI; Barrett NA; Hong DI; Laidlaw TM; Legere HJ; Nallamshetty SN; Palis RI; Rao JJ; Berlin ST; Campos SM; Matulonis UA
    J Allergy Clin Immunol; 2008 Sep; 122(3):574-80. PubMed ID: 18502492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypersensitivity and desensitization to antineoplastic agents: outcomes of 189 procedures with a new short protocol and novel diagnostic tools assessment.
    Madrigal-Burgaleta R; Berges-Gimeno MP; Angel-Pereira D; Ferreiro-Monteagudo R; Guillen-Ponce C; Pueyo C; Gomez de Salazar E; Alvarez-Cuesta E
    Allergy; 2013 Jul; 68(7):853-61. PubMed ID: 23647576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential presentation of hypersensitivity reactions to carboplatin and oxaliplatin: Phenotypes, endotypes, and management with desensitization.
    Jimenez-Rodriguez TW; de Las Vecillas L; Labella M; Lynch DM; Besz KM; Marquis K; Burgos A; Soriano Gomis V; Lozano I; Antón RAM; de la Calle FM; González Delgado MP; Gutiérrez A; Montenegro E; Rodríguez F; Fernández Sánchez FJ; Castells M
    Allergy; 2024 Mar; 79(3):679-689. PubMed ID: 37916741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab Hypersensitivity: Evaluation, Desensitization, and Potential Mechanisms.
    Wong JT; Long A
    J Allergy Clin Immunol Pract; 2017; 5(6):1564-1571. PubMed ID: 29122155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxaliplatin hypersensitivity: evaluation, implications of skin testing, and desensitization.
    Wong JT; Ling M; Patil S; Banerji A; Long A
    J Allergy Clin Immunol Pract; 2014; 2(1):40-5. PubMed ID: 24565767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hypersensitivity to platinum salts and taxanes: The value of skin tests and tolerance induction procedures].
    Brault F; Waton J; Poreaux C; Schmutz JL; Barbaud A
    Ann Dermatol Venereol; 2017 Nov; 144(11):685-695. PubMed ID: 28760501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypersensitivity reactions and the utility of oral and intravenous desensitization in patients with gynecologic malignancies.
    Robinson JB; Singh D; Bodurka-Bevers DC; Wharton JT; Gershenson DM; Wolf JK
    Gynecol Oncol; 2001 Sep; 82(3):550-8. PubMed ID: 11520154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid Drug Desensitization with Chemotherapeutics (Platins, Taxanes, and Others): A Single-Center Retrospective Study.
    Kendirlinan R; Gümüşburun R; Çerçi P; Özbek E; Altıner S; Çelebi Sözener Z; Soyyiğit Ş; Aydın Ö; Bavbek S
    Int Arch Allergy Immunol; 2019; 179(2):114-122. PubMed ID: 30893688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carboplatin hypersensitivity: does introduction of skin test and desensitization reliably predict and avoid the problem? A prospective single-center study.
    Gomez R; Harter P; Lück HJ; Traut A; Kommoss S; Kandel M; du Bois A
    Int J Gynecol Cancer; 2009 Oct; 19(7):1284-7. PubMed ID: 19823066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid desensitization of hypersensitivity reactions to chemotherapy agents.
    Castells M
    Curr Drug Saf; 2006 Aug; 1(3):243-51. PubMed ID: 18690934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desensitization to rituximab in a multidisciplinary setting.
    Amorós-Reboredo P; Sánchez-López J; Bastida-Fernández C; do Pazo-Oubiña F; Borràs-Maixenchs N; Giné E; Valero A; Creus-Baró N
    Int J Clin Pharm; 2015 Oct; 37(5):744-8. PubMed ID: 25999014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does Rapid Drug Desensitization to Chemotherapy Affect Survival Outcomes?
    Berges-Gimeno MP; Carpio-Escalona LV; Longo-Muñoz F; Bernal-Rubio L; Lopez-Gonzalez P; Gehlhaar P; Pachon V; Ferreiro-Monteagudo R; Madrigal-Burgaleta R; Alvarez-Cuesta E
    J Investig Allergol Clin Immunol; 2020; 30(4):254-263. PubMed ID: 31188129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful oxaliplatin desensitization protocol in a patient with colorectal metastatic cancer.
    de Lira-Quezada CE; Villarreal-Gonzalez RV; Gonzalez-Diaz SN; Carrasco-Diaz LL
    J Oncol Pharm Pract; 2021 Mar; 27(2):490-493. PubMed ID: 32635810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of a Undiluted, One-Bag Desensitization Protocol for Chemotherapeutic Agents.
    Iglesias-Santamaría A; Castellano Copa P
    Ann Pharmacother; 2023 Jan; 57(1):55-61. PubMed ID: 35570798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.